Acetylcysteine Oral and Inhalation Solution Shortage

• • Acetylcysteine solution, Fresenius Kabi, 200 mg/mL, 10 mL vial, 3 count, NDC 63323-0692-10

• • American Regent has acetylcysteine oral and inhalation solution available.
  • Arbor discontinued Cetylev effervescent tablets in April 2019.
  • Fresenius Kabi did not provide a reason for the shortage.
  • Pfizer has acetylcysteine oral and inhalation solution available.
  • Somerset has acetylcysteine oral and inhalation solution available.

• • Acetylcysteine solution, American Regent, 100 mg/mL, 4 mL vial, 25 count, NDC 00517-7504-25
  • Acetylcysteine solution, American Regent, 200 mg/mL, 4 mL vial, 3 count, NDC 00517-7604-25
  • Acetylcysteine solution, Fresenius Kabi, 100 mg/mL, 10 mL vial, 3 count, NDC 63323-0693-10
  • Acetylcysteine solution, Fresenius Kabi, 100 mg/mL, 30 mL vial, 3 count, NDC 63323-0691-30
  • Acetylcysteine solution, Fresenius Kabi, 100 mg/mL, 4 mL vial, 25 count, NDC 63323-0695-04
  • Acetylcysteine solution, Fresenius Kabi, 200 mg/mL, 30 mL vial, 3 count, NDC 63323-0690-30
  • Acetylcysteine solution, Fresenius Kabi, 200 mg/mL, 4 mL vial, 3 count, NDC 63323-0694-04
  • Acetylcysteine solution, Pfizer, 100 mg/mL, 30 mL vial, 3 count, NDC 00409-3307-03
  • Acetylcysteine solution, Pfizer, 200 mg/mL, 30 mL vial, 3 count, NDC 00409-3308-03
  • Acetylcysteine solution, Somerset Therapeutics LLC, 100 mg/mL, 4 mL vial, 25 count, NDC 70069-0018-25
  • Acetylcysteine solution, Somerset Therapeutics LLC, 200 mg/mL, 30 mL vial, 3 count, NDC 70069-0020-03
  • Acetylcysteine solution, Somerset Therapeutics LLC, 200 mg/mL, 4 mL vial, 25 count, NDC 70069-0019-25

Estimated Resupply Dates

• • Fresenius Kabi has acetylcysteine 200 mg/mL 10 mL vials on back order and the company estimates a release date of early- to mid-July 2025.